Literature DB >> 11063896

The role of serotonin in hot flushes.

H H Berendsen1.   

Abstract

Hot flushes are experienced in those periods of the female life when estrogen levels are low. Hormone replacement therapy is thus the first choice for treatment of hot flushes. However this treatment is not always accepted or contraindicated for a variety of reasons. Estrogen (and progestogen) strongly interact with a number of neurotransmitters and this has led to a range of non-hormonal treatments including compounds that act via the noradrenergic or dopaminergic systems as well as herbal remedies. These treatments (which are shortly reviewed) are not always successful. Surprisingly, apart from treatment with some selective serotonin (5-HT) reuptake inhibitors (SSRI's), up till now, little attention is given to the strong interaction of estrogens with the serotonergic system. These interactions are shortly reviewed. Based on these interactions, a hypothesis on the genesis of hot flushes is postulated. Especially the 5-HT(2A) receptor subtype may play a key role in the occurrence of hot flushes. A number of arguments that support this hypothesis are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063896     DOI: 10.1016/s0378-5122(00)00151-1

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  40 in total

1.  Hormone variability and hot flash experience: Results from the midlife women's health study.

Authors:  Catheryne Chiang; Lisa Gallicchio; Howard Zacur; Sue Miller; Jodi A Flaws; Rebecca L Smith
Journal:  Maturitas       Date:  2018-10-23       Impact factor: 4.342

2.  Temporal sequencing of brain activations during naturally occurring thermoregulatory events.

Authors:  Vaibhav A Diwadkar; Eric R Murphy; Robert R Freedman
Journal:  Cereb Cortex       Date:  2013-06-19       Impact factor: 5.357

3.  Calcium and vitamin D supplementation do not influence menopause-related symptoms: Results of the Women's Health Initiative Trial.

Authors:  Erin S LeBlanc; Haley Hedlin; FeiFei Qin; Manisha Desai; Jean Wactawski-Wende; Nancy Perrin; JoAnn E Manson; Karen C Johnson; Kamal Masaki; Frances A Tylavsky; Marcia L Stefanick
Journal:  Maturitas       Date:  2015-06-01       Impact factor: 4.342

Review 4.  Mechanism of hot flashes.

Authors:  Santiago Vilar-González; Alberto Pérez-Rozos; Ruben Cabanillas-Farpón
Journal:  Clin Transl Oncol       Date:  2011-03       Impact factor: 3.405

5.  Tissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.

Authors:  Dale W Stovall; Kirby Tanner-Kurtz; JoAnn V Pinkerton
Journal:  Drugs       Date:  2011-09-10       Impact factor: 9.546

6.  Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial.

Authors:  Gary R Elkins; William I Fisher; Aimee K Johnson; Janet S Carpenter; Timothy Z Keith
Journal:  Menopause       Date:  2013-03       Impact factor: 2.953

7.  Serotonin receptors in platelets of bipolar and schizoaffective patients: effect of lithium treatment.

Authors:  Ghanshyam N Pandey; Subhash C Pandey; Xinguo Ren; Yogesh Dwivedi; Philip G Janicak
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

8.  Management of hot flashes in women with breast cancer.

Authors:  L Kligman; J Younus
Journal:  Curr Oncol       Date:  2010-02       Impact factor: 3.677

Review 9.  Actual status of veralipride use.

Authors:  Sebastián Carranza-Lira
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

10.  Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions.

Authors:  Deirdre R Pachman; Jason M Jones; Charles L Loprinzi
Journal:  Int J Womens Health       Date:  2010-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.